click enter text
what futur drugstor
yesterday morn rais outlook due larg part chang
 corpor tax law stronger bottom-lin result howev
obfusc believ broader issu around futur role
drugstor play consum live front-end continu see
neg store sale trend consum shop product
on-line cheaper brick mortar retail venu real challeng
appear pharmaci dispens believ amazon like
enter market take share address ineffici exist today
high-cost real estat labor model drugstor
walgreen seem understand like tri
remak drugstor experi next sever year balanc
valuat well-below histor norm signific
uncertainti around direct industri remain peer perform
rate equiti
quarter review walgreen report better-than-expect earn
yesterday morn rais outlook due larg part chang
 corpor tax law adj ep exceed street
estim equiti sinc earn report yesterday
outlook adj ep estim
pleas see page detail
valuat trade ntm consensu ep
histor averag see fair valu wba equiti low
includ purchas certain rite aid asset base approx
adj ep estim page detail
trade fundament data
price et
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
wba equiti under-perform market year wba equiti far calendar
compar declin time frame calendar wba equiti
fell under-perform rise calendar wba equiti fell
under-perform rise
trade histor averag trade ntm consensu ep
price-to-earnings averag respect ev/ebitda basi
trade ntm consensu ebitda compani ev/ebitda averag
respect
see fair valu share low estim calendar year-end fair valu
share low repres approxim adj ep estim
inclus purchas certain rite aid asset prior calendar year-end fair valu wba
equiti stand-alon basi exclud near base approxim prior
adj ep estim wba equiti trade well-below histor averag top-line continu
remain sluggish across enterpris exclud currenc acquisit time believ
signific uncertainti around direct drugstor industri competitor amazon
like enter well question around role drugstor play consum live futur
believ like weigh compani valuat multipl suggest could remain
prior long-term averag chosen price-to-earnings multipl larg in-lin compani
risk peer perform rate
risk upsid
acquisit certain store creat market power could posit
implic sale profit
manag team solid track record enhanc profit well integr
acquisit continu could lead higher profit earn
save initi synergi greater-than-expect lead higher profit earn
make acquisit significantli enhanc sharehold valu
amazon enter pharmaceut dispens market
page
risk downsid
amazon decid enter pharmaceut dispens market
chang consum landscap around purchas prefer lead lower sale profit
compani
pharmacy-rel reimburs pressur reduc profit anticip
long-term viabil drugstor wane particularli lead reduc sale profit
walgreen given larg store base
compani equiti valuat move lower drugstor model becom less favor channel
consum shop goods/ prescript
compani lower rel busi transpar lead contract earn multipl result
reduct equiti price
wba global footprint creat less visibl wba oper also expos compani
compani higher-cost horizont model lead weaken competit posit long-term
rel peer vertically-ori
earn driver outlook
updat forecast reflect stage purchas certain rite aid asset quarterli
result adj ep estim toward middl compani guidanc
rang current fiscal year legaci retail pharmaci usa busi exclud rite aid
forecast back half year reflect pharmaci comp sale front-end comp sale
estim slight oper margin expans modest
contract latter driven difficult comparison last year fourth quarter respect
forecast balanc acquir store transfer partial off-set store
closur compani optim store network retail pharmaci intern segment
forecast low singl digit neg sale growth constant currenc basi
coupl slight oper margin expans compani focus cost reduct off-set sale
pressur pharmaceut wholesal segment second half forecast low singl digit posit
sale growth constant currenc basi well margin expans due equiti method earn
contribut combin factor along prior quarterli result lead adj oper
incom adj ep
page
estim adj ep compani legaci retail pharmaci usa segment
forecast store sale compris pharmaci comp sale slightli declin front-
end sale also forecast modest oper margin eros perspect factor
stage transfer store off-set on-going ration store network also
forecast ramp synergi benefit retail pharmaci intern segment forecast
slightli declin constant currenc net sale growth slight oper margin compress
pharmaceut wholesal segment forecast low singl digit posit constant currenc net sale growth
oper margin expans driven equiti method earn
page
earn outlook outlook segment retail pharmaci usacost net gross adj oper retail pharmaci internationalequ incom invest allianc boots- net equiti method earn adj oper ebit wholesaleadj oper net adj oper interest expens incom corpor elimin otheroth incom net- net ebit adj oper incom marginretail pharmaci net incom fifo retail pharmaci dilut ep fifo consensu weight average dilut share growth ratesnet gross sg net ebit adj oper net incom dilut fifo ep margin gross sg net ebit adj oper chang margingross sg net ebit adj oper tax
highlight thought earn call
drugstor like look lot differ year manag note need store
chang significantli futur highlight servic would need offer captur
custom mindshar drugstor format larg unchang decad whether
tradit food retail food manufactur issu catch everyon off-guard consum
chang rapidli broadli re-evalu want interact good commerc mani brick
mortar retail manufactur signific lack innov recent decad old
busi model attack front new entrant look grab market share
sleep giant unfortun drugstor price front-end still high compar
certain stapl retail drugstor may dub conveni consum pass
way home work much front-end found on-line shop even
conveni fashion product deliv home particularli think stand
check-out line would also note grow presenc dollar store offer similar conveni
drugstor lower price continu believ front-end remain pressur
forese futur comp like reflect
retail pharmaci model jeopardi mind pharmaci like
competitor come year knock door tri make process cheaper enjoy
easier consum amazon like one opinion compani tri
disrupt pharmaci model take step back hard see lot ineffici way
prescript fill given technolog avail said agre drug retail need
vastli chang approach stand-alone drugstor offer servic certainli much lower
price solv issu probabl see box gener lose favor time lead
need closur
what drugstor like tradit stapl retail oper need find way convinc
consum best interest actual come store similarli drugstor need follow-suit
give consum compel reason shop store offer servic provid solut
cant found elsewher particularli compel price bottom line howev whether drug retail
stapl retail remak fit today consum tomorrow consum want like
costli believ sale like remain pressur organ basi margin
like pay price well stay relev greatest challeng compani
store today like go need futur
what sale inde look across wba three busi segment quarter base
busi put gener poor sale result pharmaci comp remain robust given prior
partnership comp sale front-end took notic step quarter compani call
effort drive improv profit agre drive profit sale utmost import sale
nevertheless lifeblood retail peopl arent come store buy product front-
end neg implic profit long-term store busi comp
sale front-end shrank similar quarter wholesal busi sale also
compani expect take step back compani time done laudabl job take cost
busi sale continu remain lacklust hard envis environ
chang drastic posit long-term believ put increas pressur
compani forc addit consolid cost-cut program run cours
page
quarter review
walgreen report better-than-expect earn yesterday morn rais outlook due
larg part chang corpor tax law adj ep exceed street
estim consolid basi net sale billion roughli ahead street
adj oper incom compar street oper incom estim
 busi comp sale slightli street comp sale front-end
repres deceler recent perform across board sale retail busi
retail busi wholesal oper notabl sluggish exclud currenc
acquisit compani rais forecast adj ep full year driven larg benefit tax
reform anticip adj ep rang equiti rose yesterday
et today sinc earn report
page
